Parke Davis Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PARKE DAVIS, and what generic and branded alternatives to PARKE DAVIS drugs are available?
PARKE DAVIS has one hundred approved drugs.
Drugs and US Patents for Parke Davis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Parke Davis | PITRESSIN TANNATE | vasopressin tannate | INJECTABLE;INJECTION | 003402-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Parke Davis | HYDROCORTISONE | hydrocortisone | TABLET;ORAL | 084243-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Parke Davis | PENAPAR-VK | penicillin v potassium | TABLET;ORAL | 062001-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Parke Davis | METHYLDOPA | methyldopa | TABLET;ORAL | 070332-001 | Apr 15, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Parke Davis | SPIRONOLACTONE W/ HYDROCHLOROTHIAZIDE | hydrochlorothiazide; spironolactone | TABLET;ORAL | 087948-001 | Feb 22, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Parke Davis | NARDIL | phenelzine sulfate | TABLET;ORAL | 011909-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Parke Davis | UTICORT | betamethasone benzoate | GEL;TOPICAL | 017244-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Parke Davis
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Parke Davis | CHOLYBAR | cholestyramine | BAR, CHEWABLE;ORAL | 071621-001 | May 26, 1988 | 4,778,676 | ⤷ Try a Trial |
Parke Davis | CEREBYX | fosphenytoin sodium | INJECTABLE;INJECTION | 020450-001 | Aug 5, 1996 | 4,260,769 | ⤷ Try a Trial |
Parke Davis | CEREBYX | fosphenytoin sodium | INJECTABLE;INJECTION | 020450-001 | Aug 5, 1996 | 4,925,860 | ⤷ Try a Trial |
Parke Davis | FEMPATCH | estradiol | FILM, EXTENDED RELEASE;TRANSDERMAL | 020417-001 | Dec 3, 1996 | 5,006,342 | ⤷ Try a Trial |
Parke Davis | CHOLYBAR | cholestyramine | BAR, CHEWABLE;ORAL | 071739-001 | May 26, 1988 | 4,778,676 | ⤷ Try a Trial |
Parke Davis | FEMPATCH | estradiol | FILM, EXTENDED RELEASE;TRANSDERMAL | 020417-001 | Dec 3, 1996 | 4,906,463 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for PARKE DAVIS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Sublingual Tablets | 0.3 mg, 0.4 mg and 0.6 mg | ➤ Subscribe | 2005-10-19 |
➤ Subscribe | Sublingual Tablets | 0.6 mg | ➤ Subscribe | 2011-12-29 |
Similar Applicant Names
Here is a list of applicants with similar names.